4,438 results found

In a 2021 Risk Review, the FDIC underscored intensified credit and market risks arising from the COVID-19 pandemic.

FINRA proposed rule amendments to provide the self-regulatory agency temporary relief from certain enforcement and other procedural requirements while operations are impacted by the coronavirus.

The Federal Communications Commission (FCC) released a Public Notice announcing that the application filing window for Round 2 of its COVID-19

On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) announced in an MLN Special Edition the release of its annual Physician Fee Schedule final rule

Episode five of McGuireWoods' video series "Healthcare Headlines" is now available.

On August 22, Moderna announced that FDA approved its supplemental Biologics License Application ("sBLA") for a new formula of their COVID-19 vaccine...

Late last week, the U.S. Food and Drug Administration (FDA) announced it approved the use of spun synthetic swabs similar to Q-tips for use in testing for COVID-19.

Hospitals, physician practices, and other provider organizations are dealing with unprecedented challenges in the present public health emergency following the spread of the novel coronavirus (COVID-19).

Mounting anxiety over how to control the spread of infectious disease outbreaks encourages public and political discourse of bioethics.

The Department of Labors Office of Foreign Labor Certification has issued Round 4 of its frequently asked questions related to the Labor Condition Application for the H-1B, H-1B1 and E-3 visa programs.

In the first of a series of videos discussing developments in trade secret litigation, Mintz's Nick Armington explains why the volume of trade secret litigation in state and federal courts is expected to greatly increase over the next five years

The World Intellectual Property Organization (WIPO) has launched the COVID-19 IP Policy Tracker, a tool that provides information on pandemic-related IP office policy changes.

The Office of the U.S. Trade Representative (USTR) has announced that it will again extend Section 301 product exclusions for imports from China of medical care products needed to address the COVID-19 pandemic.

There were 44 confirmed cases of COVID at the home and 12 confirmed deaths.

IOSCO emphasized the importance of going concern financial disclosure for public companies during the COVID-19 pandemic.

In this episode, Akin Gump antitrust partners Gorav Jindal and Corey Roush, fresh off a two-week trial, discuss the nuts and bolts of litigating during the COVID-19 pandemic.

The New NAFTA, known as USMCA (in U.S.), CUSMA (in Canada) and T-MEC (in Mexico), will enter into force on July 1, 2020 (or later). As the world focuses on business resumption and recovery in the...

In an April 28th letter authored by the American Trade Association for Cannabis and Hemp (ATACH) and the Policy Center for Public Health and Safety...